Division of Hospital Medicine, Children's Mercy Kansas City, Kansas City, MO, United States; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
University of Colorado School of Medicine, Department of Pediatrics Pediatric Pulmonary and Sleep Medicine Section, United States; Children's Hospital Colorado, Breathing Institute, United States.
J Pharm Sci. 2024 Jan;113(1):47-54. doi: 10.1016/j.xphs.2023.10.016. Epub 2023 Oct 14.
This review will highlight portions of Dr. William Jusko's and colleagues' work that affected the clinical use and study of corticosteroids in acute and chronic disease management. Selected publications related to corticosteroid pharmacokinetics and pharmacodynamics from the 1970s through today were included in this review, with a focus on the foundational human-based studies conducted in the 1970s-1990s. Dr. Jusko contributed significantly to early corticosteroid pharmacology across several domains including: 1) foundational corticosteroid pharmacokinetic methods and parameter development, 2) disease state-variation in corticosteroid pharmacokinetics, 3) drug interaction effects on corticosteroid pharmacokinetics, and 4) early corticosteroid pharmacodynamic studies. In an era where little was known about the pharmacokinetics and pharmacodynamics of corticosteroids, Dr. Jusko's work opened the eyes of researchers and clinicians to the potential for disease and drug interactions that could reduce or enhance the effects of corticosteroids. This significant body of work paved the way for alternative routes of administration that would be useful in concentrating the activity at the site of action and markedly reduced systemic drug exposure, minimizing the risk of adverse effects through application of the dose-sparing pharmacokinetic and pharmacodynamic principles.
这篇综述将重点介绍 William Jusko 博士及其同事的部分工作,这些工作影响了皮质类固醇在急性和慢性疾病管理中的临床应用和研究。本综述纳入了 20 世纪 70 年代至今与皮质类固醇药代动力学和药效学相关的部分出版物,重点关注 20 世纪 70 年代至 90 年代开展的基于人体的基础研究。Jusko 博士在多个领域为皮质类固醇药理学的早期发展做出了重要贡献,包括:1)皮质类固醇药代动力学的基础方法和参数开发;2)疾病状态对皮质类固醇药代动力学的影响;3)药物相互作用对皮质类固醇药代动力学的影响;4)皮质类固醇药效学的早期研究。在皮质类固醇药代动力学和药效学知之甚少的时代,Jusko 博士的工作使研究人员和临床医生意识到疾病和药物相互作用的可能性,这些可能性可能会降低或增强皮质类固醇的作用。这项重要的工作为替代给药途径铺平了道路,这些途径将有助于在作用部位集中药物活性,并显著减少全身药物暴露,通过应用剂量节约的药代动力学和药效学原则将不良反应的风险降至最低。